Literature DB >> 19618542

How health care reform can lower the costs of insurance administration.

Sara R Collins1, Rachel Nuzum, Sheila D Rustgi, Stephanie Mika, Cathy Schoen, Karen Davis.   

Abstract

The United States leads all industrialized countries in the share of national health care expenditures devoted to insurance administration. The U.S. share is over 30 percent greater than Germany's and more than three times that of Japan. This issue brief examines the sources of administrative costs and describes how a private-public approach to health care reform--with the central feature of a national insurance exchange (largely replacing the present individual and small-group markets)--could substantially lower such costs. In three variations on that approach, estimated administrative costs would fall from 12.7 percent of claims to an average of 9.4 percent. Savings--as much as $265 billion over 2010-2020--would be realized through less marketing and underwriting, reduced costs of claims administration, less time spent negotiating provider payment rates, and fewer or standardized commissions to insurance brokers.

Mesh:

Year:  2009        PMID: 19618542

Source DB:  PubMed          Journal:  Issue Brief (Commonw Fund)        ISSN: 1558-6847


  4 in total

1.  A modified "Golden Rule" for health care organizations.

Authors:  Creagh E Milford; Timothy G Ferris
Journal:  Mayo Clin Proc       Date:  2012-08       Impact factor: 7.616

2.  Improving healthcare value: Addressing the confusing costs of observation hospitalizations.

Authors:  Farah A Kaiksow; W Ryan Powell; Charles F Locke; Bartho Caponi; Amy J H Kind; Ann M Sheehy
Journal:  J Hosp Med       Date:  2022-01-15       Impact factor: 2.899

3.  Billing and insurance-related administrative costs in United States' health care: synthesis of micro-costing evidence.

Authors:  Aliya Jiwani; David Himmelstein; Steffie Woolhandler; James G Kahn
Journal:  BMC Health Serv Res       Date:  2014-11-13       Impact factor: 2.655

4.  Cost Analyses in the US and Japan: A Cross-Country Comparative Analysis Applied to the PRONOUNCE Trial in Non-Squamous Non-Small Cell Lung Cancer.

Authors:  Lisa M Hess; Narayan Rajan; Katherine Winfree; Peter Davey; Mark Ball; Hediyyih Knox; Christopher Graham
Journal:  Adv Ther       Date:  2015-12-09       Impact factor: 3.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.